These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20938724)

  • 21. Serum IL-21 levels from celiac disease patients correlates with anti-tTG IgA autoantibodies and mucosal damage.
    Iervasi E; Auricchio R; Strangio A; Greco L; Saverino D
    Autoimmunity; 2020 Jun; 53(4):225-230. PubMed ID: 32157915
    [No Abstract]   [Full Text] [Related]  

  • 22. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
    Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
    Steinsbø Ø; Dørum S; Lundin KE; Sollid LM
    Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
    Albuquerque A; Rodrigues S; Macedo G
    Scand J Gastroenterol; 2016 Nov; 51(11):1316-20. PubMed ID: 27387923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
    Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
    Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
    Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis.
    Salmi TT; Kurppa K; Hervonen K; Laurila K; Collin P; Huhtala H; Saavalainen P; Sievänen H; Reunala T; Kaukinen K
    Dig Liver Dis; 2016 Jun; 48(6):632-7. PubMed ID: 27026081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to tissue transglutaminase as predictors of celiac disease.
    Dieterich W; Laag E; Schöpper H; Volta U; Ferguson A; Gillett H; Riecken EO; Schuppan D
    Gastroenterology; 1998 Dec; 115(6):1317-21. PubMed ID: 9834256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
    Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
    Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney.
    Abbad L; Monteiro RC; Berthelot L
    Mol Immunol; 2020 May; 121():1-6. PubMed ID: 32135400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease.
    Fernández E; Blanco C; García S; Dieguez A; Riestra S; Rodrigo L
    Clin Chem; 2005 Jun; 51(6):1014-6. PubMed ID: 15790754
    [No Abstract]   [Full Text] [Related]  

  • 35. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J; Barratt J; Julian BA; Renfrow MB
    Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA antiepidermal transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free diet treatment.
    Reunala T; Salmi TT; Hervonen K; Laurila K; Kautiainen H; Collin P; Kaukinen K
    Br J Dermatol; 2015 Apr; 172(4):1139-41. PubMed ID: 25196300
    [No Abstract]   [Full Text] [Related]  

  • 37. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early microbial markers of celiac disease.
    Viitasalo L; Niemi L; Ashorn M; Ashorn S; Braun J; Huhtala H; Collin P; Mäki M; Kaukinen K; Kurppa K; Iltanen S
    J Clin Gastroenterol; 2014 Aug; 48(7):620-4. PubMed ID: 24518796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential celiac children: 9-year follow-up on a gluten-containing diet.
    Auricchio R; Tosco A; Piccolo E; Galatola M; Izzo V; Maglio M; Paparo F; Troncone R; Greco L
    Am J Gastroenterol; 2014 Jun; 109(6):913-21. PubMed ID: 24777149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.